Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jun 13:16:1633600.
doi: 10.3389/fphar.2025.1633600. eCollection 2025.

Editorial: Multi-target drug discovery and design for complex health disorders

Affiliations
Editorial

Editorial: Multi-target drug discovery and design for complex health disorders

Farid A Badria et al. Front Pharmacol. .
No abstract available

Keywords: drug design; drug discovery; health disorders; in silico drug discovery; multitarget; natural products.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Multi-Target Drug Discovery and Design for Complex Health Disorders

References

    1. Alcaro S., Bolognesi M. L., García-Sosa A. T., Rapposelli S. (2019). Editorial: multi-target-directed ligands (MTDL) as challenging research tools in drug discovery: from design to pharmacological evaluation. Front. Chem. 7, 71. 10.3389/fchem.2019.00071 - DOI - PMC - PubMed
    1. Cerchia C., Lavecchia A. (2023). New avenues in artificial-intelligence-assisted drug discovery. Drug Discov. Today 28, 103516. 10.1016/j.drudis.2023.103516 - DOI - PubMed
    1. De Sena Murteira Pinheiro P., Franco L. S., Montagnoli T. L., Fraga C. A. M. (2024). Molecular hybridization: a powerful tool for multitarget drug discovery. Expert Opin. Drug Discov. 19, 451–470. 10.1080/17460441.2024.2322990 - DOI - PubMed
    1. Ibrahim M. G., El-Senduny F. F., Youssef M. M., Elimam D. M., Bar F. M. A., Badria F. A. (2019). Acetyl glycyrrhetinic acid methyl ester as a promising glycyrrhizin derivative against the breast cancer cells (MCF-7). J. Rep. Pharm. Sci. 8, 161. 10.4103/jrptps.jrptps_60_18 - DOI
    1. Maruca A., Catalano R., Bagetta D., Mesiti F., Ambrosio F. A., Romeo I., et al. (2019). The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile. Eur. J. Med. Chem. 181, 111579. 10.1016/j.ejmech.2019.111579 - DOI - PubMed

Publication types

LinkOut - more resources